HCA Healthcare (NYSE:HCA) Stock Price Expected to Rise, Barclays Analyst Says
HCA Healthcare (NYSE:HCA – Get Free Report) had its target price increased by investment analysts at Barclays from $366.00 to $416.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 8.55% from the company’s previous close. Several […]
HCA Healthcare (NYSE:HCA – Get Free Report) had its target price increased by investment analysts at Barclays from $366.00 to $416.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 8.55% from the company’s previous close. Several […]
